Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

SGI-110

A substance being studied in the treatment of some types of cancer. SGI-110 may stop the growth of tumor cells by blocking some of the enzymes needed for cells to divide. It may also make cancer cells more sensitive to other anticancer drugs. SGI-110 is a type of antimetabolite Also called guadecitabine.

SGI-110

Search NCI's Dictionary of Cancer Terms